Description

+ Include: 37 videos + 31 pdfs, size: 15.6 GB

+ Target Audience: internists, oncologists, hematologists as well as medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in the diagnosis, treatment, and biomedical research of lymphoma

+ Sample video: contact me for sample video

+ Information:

We are excited to welcome attendees back to New York City for the 7th Annual MSK Symposium on Lymphoma. This Symposium will feature updated information on lymphoma biology, diagnosis, and ongoing efforts to translate scientific discoveries into novel treatment strategies for a variety of lymphoma subtypes.

This year, we will address the clinical management of the most frequent lymphoma entities and will feature focused sessions related to new families of drugs being developed in these areas as well as in less common presentations. Faculty will present those and then discuss, during a panel, how to best approach patients’ situations. We will also cover, in a special session, recent advances in the biology of lymphoma and how these will translate to innovative therapeutic interventions

Highlights of this year’s hybrid program include:

FRIDAY, MAY 5

Afternoon Breakout Sessions – Two concurrent breakout sessions will be held on Friday afternoon. Selection for the breakout sessions must be made during your registration. Options include:

• Science in Progress (In-person or Virtual)
• Nursing Professional Development (In-person Only) – Space is very limited for this breakout. We encourage early registration and ask registrants to ONLY make this selection if you are confirmed to participate in the session in its entirety.

Networking Reception (In-person Only) – In-person attendees are invited to join the Symposium faculty for a networking reception on Friday evening. This event will be held in the lobby of Zuckerman Research Center and RSVP is required. If you are interested in joining the reception, please be sure to select this as an option in your registration. Hors d’oeuvre and refreshments will be served.

SATURDAY, MAY 6

Breakfast Symposium: Chronic Lymphocytic Leukemia (In-person Only) – A special breakfast symposium will be held for in-person attendees on Saturday morning. Space is limited; we ask registrants to ONLY make this selection at registration if you are confirmed to participate.

Luncheon Session: What’s new in Multiple Myeloma (In-person Only) – A special luncheon session will be held at the end of the program on Saturday for in-person attendees. Space is limited for this session; we ask registrants to ONLY make this selection at registration if you are confirmed to participate.

Who Should Attend

The target audience for this Symposium includes internists, oncologists, hematologists as well as medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in the diagnosis, treatment, and biomedical research of lymphoma.

1. Describe recent refinements in lymphoma classification
2. Discuss first line treatment options in most frequent lymphoma entities
3. Describe new agents mode of actions, efficacy, side effects
4. Discuss options and recommendations for patients in the relapse refractory setting
5. Provide adequate information to help shared decision with patients regarding their treatment

+ Topics:

Advancing Immune Therapies in Hodgkin Lymphoma.mp4

Advancing Immune Therapies in Hodgkin Lymphoma.pdf

Advancing Immune Therapies in T-cell Lymphoma.mp4

Advancing Immune Therapies in T-cell Lymphoma.pdf

Approaches to Upfront Therapy in T-cell Lymphoma.mp4

Approaches to Upfront Therapy in T-cell Lymphoma.pdf

Bispecific Antibodies- How and When.mp4

Bispecific Antibodies- How and When.pdf

Bispecific Antibodies- Management.mp4

Bispecific Antibodies- Management.pdf

Bispecific Antibodies- Moving the Field Forward.mp4

Bispecific Antibodies- Moving the Field Forward.pdf

CAR T Cell Management.mp4

CAR T Cell Management.pdf

CAR T-cell for Follicular Lymphoma- Success and Limitations.mp4

CAR T-cell for Follicular Lymphoma- Success and Limitations.pdf

CAR T-cell- Success and Limitations.mp4

CAR T-cell- Success and Limitations.pdf

Conquering the Genetic Heterogeneity of Aggressive Lymphomas With Multi-Agent Synergistic Drug Therapy.mp4

Conquering the Genetic Heterogeneity of Aggressive Lymphomas With Multi-Agent Synergistic Drug Therapy.pdf

First Line Therapy- Can We Move the Needle Forward.mp4

First Line Therapy- Can We Move the Needle Forward.pdf

Follicular Lymphoma Roundtable Discussion QA.mp4

From Target to Compounds- BTK.pdf

From Target to Compounds- EZH2.mp4

From Target to Compounds- EZH2.pdf

From Target to Compounds- IDH.mp4

From Target to Compounds- PD1.mp4

From Target to Compounds- PD1.pdf

Hodgkin Lymphoma Roundtable Discussion QA.mp4

Is Standard of Care Still Standard in 1st Line..mp4

Is Standard of Care Still Standard in 1st Line..pdf

Is the Standard of Care in 1st Line Changing.mp4

Is the Standard of Care in 1st Line Changing.pdf

Large B-Cell Lymphoma Roundtable Discussion QA.mp4

Lymphoma Overview- What Is New.mp4

Lymphoma Overview- What Is New.pdf

Lymphoma2023_Brochure.pdf

Managing CLL Recurrence.mp4

Managing CLL Recurrence.pdf

Managing Rare T-cell Lymphomas.mp4

Managing Rare T-cell Lymphomas.pdf

Managing Recurrent Disease.mp4

Managing Recurrent Disease.pdf

Mantle Cell lymphoma Roundtable Discussion QA.mp4

New Agents, New Options.mp4

New Agents, New Options.pdf

New Therapeutic Agents in Lymphoma.mp4

New Therapeutic Agents in Lymphoma.pdf

Newly Diagnosed CLL.mp4

Newly Diagnosed CLL.pdf

Newly Diagnosed Multiple Myeloma.mp4

Newly Diagnosed Multiple Myeloma.pdf

Nursing Professional Development Roundtable Discussion QA.mp4

Radiation Therapy for Localized Stages.mp4

Radiation Therapy for Localized Stages.pdf

Relapsed Multiple Myeloma.mp4

Relapsed Multiple Myeloma.pdf

Science in Progress Roundtable Discussion QA.mp4

Special Session- CAR T cells- Update on Eligibility and Toxicity.mp4

Special Session- CAR T cells- Update on Eligibility and Toxicity.pdf

Special Session- Interpreting Real Life Data.mp4

Special Session- Interpreting Real Life Data.pdf

Special Session- Late Effects of Therapy.mp4

Special Session- Late Effects of Therapy.pdf

Special Session- Lymphoma Classifications- How to Navigate..mp4

Special Session- Lymphoma Classifications- How to Navigate..pdf

T-cell Lymphoma Roundtable Discussion QA.mp4